Newron Pharmaceuticals S.p.A. (ETR:NP5)
Germany · Delayed Price · Currency is EUR 21.50
+0.50 (2.38%)
At close: Feb 13, 2026
109.96% (1Y)
| Market Cap | 436.68M +128.1% |
| Revenue (ttm) | 59.88M +759.1% |
| Net Income | 25.33M |
| EPS | 1.19 |
| Shares Out | n/a |
| PE Ratio | 17.24 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,006 |
| Average Volume | 10,592 |
| Open | 21.25 |
| Previous Close | 21.00 |
| Day's Range | 21.25 - 22.30 |
| 52-Week Range | 6.03 - 34.65 |
| Beta | 0.70 |
| RSI | 42.45 |
| Earnings Date | Mar 24, 2026 |